Learn more

GRACEWAY PHARMACEUTICALS LLC

Overview
  • Total Patents
    80
About

GRACEWAY PHARMACEUTICALS LLC has a total of 80 patent applications. Its first patent ever was published in 2004. It filed its patents most often in United States, Canada and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and environmental technology are WEX MEDICAL INSTRUMENTATION CO, NOVACEA INC and NOWILL ALEXANDRE EDUARDO.

Patent filings per year

Chart showing GRACEWAY PHARMACEUTICALS LLCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Lee James H 37
#2 Nordsiek Michael T 28
#3 Balaji Kodumudi S 28
#4 Kulp James H 26
#5 Levy Sharon F 26
#6 Meng Tze-Chiang 26
#7 Wu Jason J 26
#8 Bahm Valyn S 25
#9 Babilon Robert 24
#10 Statham Alexis S 8

Latest patents

Publication Filing date Title
CA2713777A1 Pump systems and methods for storing and dispensing a plurality of precisely measured unit-doses of imiquimod cream
CA2697978A1 Lower dosage strength imiquimod formulations and short dosing regimens for treating genital warts
UA110459C2 Pharmaceutical formulations of imiquimod and method for treating actinic keratosis
AU2009335943A1 Lower dosage strength imiquimod formulations and short dosing regimens for treating actinic keratosis
CA2709732A1 Lower dosage strength imiquimod formulations and short dosing regimens for treating actinic keratosis
CA2649893A1 Lower dosage strength imiquimod formulations and short dosing regimens for treating actinic keratosis
CA2679067A1 Method and packages to enhance safety when using imiquimod to treat children diagnosed with skin disorders
WO2008118763A1 Methods and packages to enhance safety when using imiquimod to treat children diagnosed with skin disorders
WO2008118765A1 Methods and packages to enhance safety when using imiquimod to treat children diagnosed with skin disorders
WO2008118762A1 Methods and packages to enhance safety when using imiquimod to treat children diagnosed with skin disorders
WO2008098232A1 Methods of treating dermatological disorders and inducing interferon biosynthesis with shorter durations of imiquimod therapy
AU2007281224A1 Methods and pharmaceutical compositions to treat gastric acid disorders
CA2664548A1 Packaging for 1-(2-methylpropyl)-1h-imidazo[4,5-c]quinolin-4-amine-containing formulation
BRPI0621407A2 oleic acid-containing immune response modifying pharmaceutical formulations, stabilization processes thereof and use of a sister immune response modifying compound